D Arikan Selected Research

Adalimumab (Humira)

1/2019	Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis.
12/2018	Systematic review of the real-world evidence of adalimumab safety in psoriasis registries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

D Arikan Research Topics

Disease

2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 12/2018
2	Flushing 01/2016 - 08/2015
2	Tachycardia (Tachyarrhythmias) 01/2016 - 08/2015
1	Necrosis 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Anemia 01/2008
1	Leiomyomatosis 01/2008
1	Leiomyoma (Uterine Fibroids) 01/2008
1	Neoplasms (Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

2	Adalimumab (Humira)FDA Link 01/2019 - 12/2018
2	valethamateIBA 01/2016 - 08/2015
1	Monoclonal AntibodiesIBA 01/2019
1	Pharmaceutical PreparationsIBA 12/2018
1	EsapentIBA 12/2018

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2008
1	Hysterectomy 01/2008